ストックスクリーナーアプリを入手
3.96
1.02%
0.04
前日終値:
$3.92
開ける：
$3.89
24時間の取引高:
648.90K
Relative Volume:
0.91
時価総額：
$236.01M
収益：
$40.37M
当期純損益:
$-119.72M
株価収益率:
-1.941
EPS:
-2.0402
ネットキャッシュフロー:
$-135.06M
1週間 パフォーマンス:
+0.00%
1か月 パフォーマンス:
-3.65%
6か月 パフォーマンス:
-23.11%
1年 パフォーマンス:
+27.33%
1日の値動き範囲:
$3.86
$4.005
1週間の範囲:
$3.755
$4.06
52週間の値動き範囲:
$2.645
$5.55
Voyager Therapeutics Inc Stock (VYGR) Company Profile
名前
Voyager Therapeutics Inc
セクター
電話
857-259-5340
住所
75 HAYDEN AVENUE, LEXINGTON, MA
Compare VYGR vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VYGR
Voyager Therapeutics Inc
|
3.96 | 233.63M | 40.37M | -119.72M | -135.06M | -2.0402 |
VRTX
Vertex Pharmaceuticals Inc
|
446.78 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
767.85 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.50 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.28 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.42 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Voyager Therapeutics Inc Stock (VYGR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-10 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-12-02 | 開始されました | Citigroup | Buy |
| 2024-11-29 | 再開されました | Wedbush | Outperform |
| 2024-10-16 | 開始されました | Leerink Partners | Outperform |
| 2024-03-26 | 開始されました | Guggenheim | Buy |
| 2024-03-19 | 開始されました | H.C. Wainwright | Buy |
| 2024-03-07 | 開始されました | Citigroup | Buy |
| 2024-01-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-05-10 | 開始されました | Truist | Buy |
| 2023-03-10 | 開始されました | Oppenheimer | Outperform |
| 2021-10-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2021-02-03 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-12-24 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-12-23 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-11-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-11-10 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-11-10 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-03-19 | 開始されました | The Benchmark Company | Buy |
| 2020-02-06 | 開始されました | Oppenheimer | Outperform |
| 2018-11-15 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-09-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-06-04 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-12 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-03-12 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-02-02 | 開始されました | Morgan Stanley | Overweight |
| 2017-11-28 | 再開されました | Piper Jaffray | Overweight |
| 2017-10-31 | 開始されました | Robert W. Baird | Outperform |
| 2017-10-27 | 開始されました | Canaccord Genuity | Buy |
| 2017-10-23 | 繰り返されました | Stifel | Buy |
| 2017-10-12 | 開始されました | Raymond James | Outperform |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-07-28 | 再開されました | Stifel | Buy |
すべてを表示
Voyager Therapeutics Inc (VYGR) 最新ニュース
Market Moves: Can Voyager Therapeutics Inc reach all time highs this year2026 Decliners & Entry Point Confirmation Alerts - baoquankhu1.vn
Volatility Watch: How does Voyager Therapeutics Inc compare to its peersDip Buying & Weekly Momentum Stock Picks - baoquankhu1.vn
If You Invested $1,000 in Voyager Therapeutics Inc (VYGR) - Stock Titan
VYGR PE Ratio & Valuation, Is VYGR Overvalued - Intellectia AI
VYGR SEC FilingsVoyager Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Voyager Therapeutics CEO Sandrock sells $44,547 in stock By Investing.com - Investing.com Canada
Voyager Therapeutics (NASDAQ:VYGR) CEO Sells $44,547.57 in Stock - MarketBeat
Voyager Therapeutics (VYGR) CEO sells shares for RSU tax withholding - stocktitan.net
Voyager Therapeutics (VYGR) awards 50,000 RSUs to legal chief - Stock Titan
Voyager Therapeutics (NASDAQ:VYGR) Shares Pass Below 50-Day Moving AverageShould You Sell? - MarketBeat
Issuer (NASDAQ: VYGR) Form 144 — 11,511 common shares listed - Stock Titan
VYGR Forecast, Price Target & Analyst Ratings | VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) - ChartMill
Will Voyager Therapeutics Inc stock hit new highs in YEARWeekly Profit Summary & Stock Portfolio Risk Control - baoquankhu1.vn
Voyager Therapeutics (VYGR) price target increased by 12.22% to 17.17 - MSN
Market Overview: Is GCMGW showing insider buying2026 Fundamental Recap & Real-Time Buy Signal Alerts - baoquankhu1.vn
Gap Down: How does Voyager Therapeutics Inc compare to its peersMarket Movement Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Returns Recap: Is Voyager Therapeutics Inc subject to activist investor interest2026 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Activity Recap: Is Voyager Therapeutics Inc subject to activist investor interest2026 Price Action Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Vanguard disaggregates holdings after realignment (VYGR) — reports 0% ownership - Stock Titan
Voyager Therapeutics (NASDAQ:VYGR) Stock Rating Upgraded by Truist Financial - Defense World
Voyager Therapeutics (NASDAQ:VYGR) Upgraded to Strong-Buy at Truist Financial - marketbeat.com
Short Covering: Can Voyager Therapeutics Inc reach all time highs this year2026 Sector Review & Breakout Confirmation Alerts - baoquankhu1.vn
Citi Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Is Voyager Therapeutics Inc stock a smart retirement pickMarket Trend Review & Breakout Confirmation Alerts - baoquankhu1.vn
Voyager Therapeutics Conference: CEO Calls 2026 “Year of Tau,” Eyes BBB Capsid Clinic Debut - Yahoo Finance
Published on: 2026-03-22 03:58:04 - baoquankhu1.vn
HC Wainwright Analysts Increase Earnings Estimates for VYGR - MarketBeat
Voyager Therapeutics at Stifel 2026 CNS Forum: Year of Tau Focus - Investing.com Canada
H.C. Wainwright reiterates Voyager Therapeutics stock rating at buy By Investing.com - Investing.com Canada
Analysts Set Expectations for VYGR Q1 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Merit Medical Systems (MMSI), Voyager Therapeutics (VYGR) and Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail
Voyager Therapeutics (VYGR): Analyst Reiterates Buy Rating and M - GuruFocus
Voyager Therapeutics' (VYGR) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat
Truist reiterates Buy on Voyager Therapeutics stock ahead of data By Investing.com - Investing.com Canada
Truist reiterates Buy on Voyager Therapeutics stock ahead of data - Investing.com
Voyager Therapeutics Stock (ISIN: US92916U1025) Eyes Major Upside Amid Gene Therapy Pipeline Momentu - AD HOC NEWS
Voyager Therapeutics (NASDAQ:VYGR) Upgraded to Hold at Wall Street Zen - MarketBeat
Insider Trends: Can Voyager Therapeutics Inc reach all time highs this year - baoquankhu1.vn
Is Voyager Therapeutics (VYGR) Balancing Pipeline Ambition With Sustainable Losses After Its 2025 Results? - simplywall.st
Does Voyager Therapeutics’ (VYGR) Widening Annual Loss Redefine the Risk-Reward in Its Neurology Pipeline? - Yahoo Finance
Guggenheim Remains a Buy on Voyager Therapeutics (VYGR) - The Globe and Mail
Wells Fargo Sticks to Their Buy Rating for Voyager Therapeutics (VYGR) - The Globe and Mail
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Voyager Therapeutics Faces Rising Tariff and U.S.–China Geopolitical Risks as BIOSECURE Act Threatens Key Chinese CDMO Partnerships - The Globe and Mail
Voyager Therapeutics (VYGR) Gets a Buy from H.C. Wainwright - The Globe and Mail
Voyager Therapeutics (VYGR) Q4 Loss Of US$27 Million Reinforces Bearish Profitability Concerns - simplywall.st
Voyager Therapeutics, Inc. 2025 Annual Report: Key Risks, Forward-Looking Statements, and Business Overview - Minichart
Voyager Therapeutics Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia
Voyager Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Voyager Therapeutics Inc (VYGR) 財務データ
収益
当期純利益
現金流量
EPS
1.57%
1.10%
大文字化:
|
ボリューム (24 時間):